Literature DB >> 15350017

Permanent access to the portal system for cellular transplantation using an implantable port device.

Ahmed A Darwish1, Etienne Sokal, Xavier Stephenne, Mustapha Najimi, Jean de Ville de Goyet, Raymond Reding.   

Abstract

A novel application of the implantable Port-a-Cath (PAC) system is described in the context of cellular transplantation. A silicone catheter was inserted in a collateral branch of the portal vein and connected to a port device positioned subcutaneously on the left thoracic cage. This permanent vascular access allowed iterative intraportal infusions of allogenic hepatocytes without the need of repeated transhepatic catheterization of the portal vein. Using this technique, repeated infusions of cryopreserved and / or fresh hepatocytes were successfully carried out in 3 children with inborn errors of liver metabolism, with the aim of progressively providing a sufficient mass of transplanted liver cells to stabilize the metabolic condition of the patients. We suggest that this technique might also be valuable in pancreatic islet cell transplantation.

Entities:  

Mesh:

Year:  2004        PMID: 15350017     DOI: 10.1002/lt.20228

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  20 in total

1.  Hepatocyte transplantation.

Authors:  Ragai R Mitry; Robin D Hughes; Anil Dhawan
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

Review 2.  Human hepatocyte transplantation: current experience and future challenges.

Authors:  Anil Dhawan; Juliana Puppi; Robin D Hughes; Ragai R Mitry
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-04-06       Impact factor: 46.802

Review 3.  Concise Review: Liver Regenerative Medicine: From Hepatocyte Transplantation to Bioartificial Livers and Bioengineered Grafts.

Authors:  Clara T Nicolas; Raymond D Hickey; Harvey S Chen; Shennen A Mao; Manuela Lopera Higuita; Yujia Wang; Scott L Nyberg
Journal:  Stem Cells       Date:  2016-10-02       Impact factor: 6.277

4.  Improved Hepatocyte Engraftment After Portal Vein Occlusion in LDL Receptor-Deficient WHHL Rabbits and Lentiviral-Mediated Phenotypic Correction In Vitro.

Authors:  Sylvie Goulinet-Mainot; Hadrien Tranchart; Marie-Thérèse Groyer-Picard; Panagiotis Lainas; Papa Saloum Diop; Delphine Holopherne; Patrick Gonin; Karim Benihoud; Nathalie Ba; Olivier Gauthier; Dominique Franco; Catherine Guettier; Danièle Pariente; Anne Weber; Ibrahim Dagher; Tuan Huy Nguyen
Journal:  Cell Med       Date:  2012-05-08

5.  Liver transplantation for inborn errors of liver metabolism.

Authors:  Efienne M Sokal
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

6.  Hepatocyte Transplantation in Special Populations: Clinical Use in Children.

Authors:  Zahida Khan; Stephen C Strom
Journal:  Methods Mol Biol       Date:  2017

Review 7.  Liver cell transplantation for the treatment of inborn errors of metabolism.

Authors:  J Meyburg; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

8.  Clinical applications of hepatocyte transplantation.

Authors:  Giada Pietrosi; Giovanni Battista Vizzini; Salvatore Gruttadauria; Bruno Gridelli
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

9.  Clinical Hepatocyte Transplantation: What Is Next?

Authors:  James E Squires; Kyle A Soltys; Patrick McKiernan; Robert H Squires; Stephen C Strom; Ira J Fox; Alejandro Soto-Gutierrez
Journal:  Curr Transplant Rep       Date:  2017-10-14

10.  The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients.

Authors:  Marc C Hansel; Roberto Gramignoli; Kristen J Skvorak; Kenneth Dorko; Fabio Marongiu; William Blake; Julio Davila; Stephen C Strom
Journal:  Curr Protoc Toxicol       Date:  2014-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.